National Institute On Deafness And Other Communication Disorders (nidcd)

This study tests if atorvastatin, a common cholesterol drug, can reduce hearing loss caused by cisplatin chemotherapy in people with head and neck cancer. About 224 adults will either take atorvastatin or a placebo daily during and for 3 months after chemo. Hearing tests and bloo…

This study collects leftover tissue, blood, saliva, and other samples from up to 1,000 people with hearing, balance, smell, taste, voice, or swallowing disorders. The samples are stored in a biorepository for future research to better understand and diagnose these conditions. Par…

This study aims to better understand hearing instability disorders, such as Meniere's disease, by using advanced MRI scans and blood tests. Researchers will follow 210 adults aged 18-80 over 15 months to identify patterns and biomarkers linked to hearing changes. The goal is to i…

This long-term study aims to understand the genes that cause a type of inherited hearing loss called autosomal dominant hearing loss (DFNA). Researchers will follow people with DFNA and their family members for up to 20 years, using hearing tests, balance tests, blood draws, and …

This study aims to collect medical information and samples (like blood or tissue) from 600 people with hearing, balance, or communication disorders. The goal is to use this data for future research and to find candidates for other studies. Participants receive standard care and n…

This study aims to collect normal hearing and balance test results from 500 healthy volunteers aged 5 to 80. Participants will undergo various hearing and balance tests during a single visit to the NIH Clinical Center. The data will help doctors know what test results are normal …